RBC Capital lowered the firm’s price target on Acadia Healthcare (ACHC) to $17 from $19 and keeps an Outperform rating on the shares. The stock declined about 5% on Tuesday after the company announced expectations for an unmitigated $25-30M EBITDA headwind related to a new Medicaid policy in New York that would impede patients from traveling across state borders for care, the analyst tells investors in a research note.
Claim 70% Off TipRanks Premium
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on ACHC:
- Acadia Healthcare Reaffirms 2025 Financial Guidance at Conference
- Acadia Healthcare price target lowered to $17 from $22 at Mizuho
- Acadia Healthcare price target lowered to $14 from $17 at Barclays
- Video: Marvell rises after earnings, Celestial AI deal
- Acadia Healthcare price target lowered to $19 from $22 at RBC Capital